Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml.

Many efforts to reduce prostate specific antigen (PSA) overdiagnosis and overtreatment have been made. To this aim, Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) have been proposed as new more specific biomarkers. We evaluated the ability of phi and PCA3 to identify prostate cance...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Matteo Ferro, Dario Bruzzese, Sisto Perdonà, Ada Marino, Claudia Mazzarella, Giuseppe Perruolo, Vittoria D'Esposito, Vincenzo Cosimato, Carlo Buonerba, Giuseppe Di Lorenzo, Gennaro Musi, Ottavio De Cobelli, Felix K Chun, Daniela Terracciano
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Public Library of Science (PLoS) 2013-01-01
Σειρά:	PLoS ONE
Διαθέσιμο Online:	http://europepmc.org/articles/PMC3701535?pdf=render
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Prostate Health Index (Phi) and Prostate Cancer Antigen 3 (PCA3) significantly improve prostate cancer detection at initial biopsy in a total PSA range of 2-10 ng/ml.

Παρόμοια τεκμήρια